Infection and second-remission rates in patients having immunotherapy for acute myeloid keukemia.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D007239:Infections / Q000453:epidemiology*; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy*; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D001500:BCG Vaccine